Clinical Trials Logo

Clinical Trial Summary

The prevalence of addictive disorders in old age is increasing. Age specific and appropriate therapeutic concepts tailored to in-patients thus represent a promising approach for the future. The investigated therapeutic intervention is a "therapy program for integrated qualified acute treatment of alcohol and drug problems" (TIQAAM).


Clinical Trial Description

The prevalence of addictive disorders in old age is increasing. Age specific and appropriate therapeutic concepts tailored to inpatients thus represent a promising approach for the future. The investigated therapeutic intervention is a "therapy program for integrated qualified acute treatment of alcohol and drug problems" (TIQAAM).

Subjects ≥ 65 years, in which according to the WHO ASSIST V3.0 a risky consumption of alcoholic beverages, or benzodiazepines / non-benzodiazepine hypnotics (zolpidem, zopiclone, zaleplon), or both, are examined before and after a psychotherapeutic intervention during their inpatient stay exists. The data collected in part 1 of the study pertain to social integration, the motivation to change, quality of life in old age, general psychiatric symptoms. The data collected in part 2 of the study pertain to brain structure and functions. Data from standard procedures will be correlated to the data above.These relate to psychiatric symptoms, past consumption behavior, cognitive abilities, perceived social support and risk appetite. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02835144
Study type Interventional
Source Psychiatric University Hospital, Zurich
Contact
Status Terminated
Phase N/A
Start date February 2, 2017
Completion date November 15, 2017

See also
  Status Clinical Trial Phase
Completed NCT03042832 - Testing the Leadership and Organizational Change for Implementation (LOCI) Intervention N/A
Completed NCT02477280 - Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance Phase 4
Completed NCT01693978 - Contingency Outcomes in Prolonged Exposure N/A
Withdrawn NCT05448118 - Virtual MOUD Treatment- Virtual POC Toxicology N/A
Withdrawn NCT05440721 - Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification N/A
Completed NCT03694327 - Innovative Digital Therapeutic for Smoking Cessation N/A
Recruiting NCT01979133 - Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders Phase 3
Completed NCT02308878 - Mobile Health Cognitive Stimulation in Heroin Users N/A
Completed NCT01189552 - Depression Treatment for Low Income Substance Users N/A
Completed NCT01280916 - Mindful Awareness in Body-Oriented Therapy for Women's Substance Abuse Treatment Phase 1
Completed NCT02964897 - Improving Linkage to Health and Other Services for Veterans Leaving Incarceration N/A
Not yet recruiting NCT06315660 - VR Based Therapy to Treat Anxiety in Dual Diagnosis N/A
Completed NCT02579317 - Project IMPACT: In-the-Moment Protection From Automatic Capture by Trigger N/A
Completed NCT01003834 - Computerized Screening, Brief Intervention, and Referral to Treatment in Primary Care N/A
Completed NCT03538860 - Validation of an Automated Online Language Interpreting Tool - Phase Two. N/A
Completed NCT03681288 - Mindful Self Compassion for Combat Deployed Veterans With Moral Injury and Co-occurring PTSD-SUD N/A
Completed NCT02656745 - Clinical Trial of Smoking Cessation Mobile Phone Program N/A
Active, not recruiting NCT03331354 - Assessing the Effect of Distance Learning Vocational Rehabilitation on Employment Outcomes of Veterans With Psychiatric Illness and Histories of Legal Convictions N/A
Completed NCT02110693 - The Tobacco, Alcohol, Prescription Medication and Other Substances Tool N/A
Not yet recruiting NCT05415891 - The IMPROV Project: Improving Mental Health and Substance Use Treatment Provision (IMPROV) Among People Living With HIV (Human Immunodeficiency Virus) in Atlanta N/A